Submission of documents under regulation 33 of SEBI(LODR) Regulations, 2015, for the quarter ended 30.06.2024.
Awaiting price reaction for this filing.
Lords Chemicals reported very weak Q1 FY25 results with revenue from operations collapsing to just Rs 3.88 lakhs from Rs 26.79 lakhs in the same quarter last year, an ~85% drop. The company posted a net loss of Rs 7.28 lakhs (improved from Rs 34.12 lakhs loss a year ago) on total income of Rs 4.35 lakhs. The statutory auditor issued a qualified opinion citing serious concerns: fully eroded net worth, going concern doubts, negative operating cash flows, cash losses, and questionable recoverability of a Rs 85 crore advance to a related party and Rs 5.94 crore in other current assets. The company also has Rs 1.6 crore in unpaid statutory dues (income tax, excise, dividend tax) outstanding for a long period, and the Company Secretary position was vacant until May 2025. Filing itself was delayed — results for June 2024 quarter were filed only in June 2025, with FY23 and FY24 statutory audits also completed very late.
This is a deeply distressed small-cap with near-zero revenue, eroded net worth, and multiple red flags (qualified audit, going concern risk, large questionable related-party advance, unpaid statutory dues). Shareholders should expect heightened regulatory scrutiny, possible penalties, and very high risk of further value erosion; this filing is likely to weigh heavily on sentiment and could trigger price declines.